Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Alejandro Alvaro-Meca

Biographic Data

ID7449792
NAMEAlejandro Alvaro-Meca
GIVEN NAMESAlejandro
FAMILY NAMEAlvaro-Meca
SIGNATUREALVARO-MECA A
AFFILIATIONSUnit of Preventive Medicine and Public Health, Rey Juan Carlos University, Madrid, Spain
VERIFIEDNo
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2008
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Prevalence and cost of hospitalized patients with asymptomatic Covid-19 in 2020 in Spain

    Open Access•Blanca Álvarez-del Río, Laura Sánchez-de Prada et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction: COVID-19 transmission has been characterized by the presence of asymptomatic patients. Additionally, most studies evaluating costs focus on symptomatic COVID-19 cases. Objective: To describe the prevalence, characteristics, and costs of asymptomatic COVID-19 cases at admission in Spanish hospitals in 2020. Methods: A nationwide study was performed, and data of hospitalized patients were collected of the Minimum Basic Data Set in Spa…

  • Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

    Jorge Valencia, Jesús Troya et al.•ARTICLE•AIDS Care•2022

    Our objective was to evaluate the effectiveness of initiated or reinitiated antiretroviral therapy (ART) in HIV-positive active drug users receiving integrated HIV and addiction care in a harm reduction setting. We performed a study of HIV-positive persons who use drugs (PWUD) in a harm reduction unit in Madrid, Spain. Participants received HIV care integrated into addiction care and received at least one dose of observed ART based on medication-…

  • High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units

    Open Access•Jorge Valencia, Alejandro Alvaro-Meca et al.•ARTICLE•International Journal of Drug…•2019

  • Time Trend in Psychotropic Medication Use in Spain

    Open Access•Pilar Carrasco‐Garrido, Valentín Hernández-Barrera et al.•ARTICLE•International Journal of…•2016

    Background: We performed an epidemiologic study to analyze nationwide time trends in adult psychotropic drug use over a period from 2006 to 2012, and to identify those factors associated with the likelihood of consumption of these drugs during the study period; Methods: Cross-sectional study on psychotropic medication in the Spanish adult population. We used secondary individualized data drawn from the 2006 and 2012 Spanish National Health Survey…

  • Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001–2005

    Open Access•Ana Lopez-de-Andres, Ana López‐de‐Andrés et al.•ARTICLE•BMC Public Health•2008

    Rotavirus gastroenteritis remains an important cause of hospitalizations in Spanish children, mostly during the winter season

No prominent works on this page.

  • Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001–2005

    Open Access•Ana Lopez-de-Andres, Ana López‐de‐Andrés et al.•ARTICLE•BMC Public Health•2008

    Rotavirus gastroenteritis remains an important cause of hospitalizations in Spanish children, mostly during the winter season

  • Time Trend in Psychotropic Medication Use in Spain

    Open Access•Pilar Carrasco‐Garrido, Valentín Hernández-Barrera et al.•ARTICLE•International Journal of…•2016

    Background: We performed an epidemiologic study to analyze nationwide time trends in adult psychotropic drug use over a period from 2006 to 2012, and to identify those factors associated with the likelihood of consumption of these drugs during the study period; Methods: Cross-sectional study on psychotropic medication in the Spanish adult population. We used secondary individualized data drawn from the 2006 and 2012 Spanish National Health Survey…

  • High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units

    Open Access•Jorge Valencia, Alejandro Alvaro-Meca et al.•ARTICLE•International Journal of Drug…•2019

  • Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

    Jorge Valencia, Jesús Troya et al.•ARTICLE•AIDS Care•2022

    Our objective was to evaluate the effectiveness of initiated or reinitiated antiretroviral therapy (ART) in HIV-positive active drug users receiving integrated HIV and addiction care in a harm reduction setting. We performed a study of HIV-positive persons who use drugs (PWUD) in a harm reduction unit in Madrid, Spain. Participants received HIV care integrated into addiction care and received at least one dose of observed ART based on medication-…

  • Prevalence and cost of hospitalized patients with asymptomatic Covid-19 in 2020 in Spain

    Open Access•Blanca Álvarez-del Río, Laura Sánchez-de Prada et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction: COVID-19 transmission has been characterized by the presence of asymptomatic patients. Additionally, most studies evaluating costs focus on symptomatic COVID-19 cases. Objective: To describe the prevalence, characteristics, and costs of asymptomatic COVID-19 cases at admission in Spanish hospitals in 2020. Methods: A nationwide study was performed, and data of hospitalized patients were collected of the Minimum Basic Data Set in Spa…

Medicine (5 works) · Internal Medicine (4 works) · Disease (2 works) · Drug (2 works) · Environmental health (2 works) · Harm reduction (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Incidence (geometry (2 works) · Pediatrics (2 works) · Population (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae